RNS today4 Mar 2010 08:12
Positive stuff, good to see have now got enough people on board for the trials.
Was going to top up below.95 this bit of news may put a stop to that.
International Congress (XXIII) Endovascular Interventions
London, UK, 4 March 2010 - Lombard Medical Technologies PLC (AIM: LMT), a medical device company focused on device solutions for $1 billion dollar abdominal aortic aneurysm repair market, announces that Dr Peter Phillips, the Company's Chief Technology Officer and co-inventor of the Aorfix™ implant, has presented data on the use of Aorfix™ at the International Congress (XXIII) Endovascular Interventions in Phoenix, Arizona (1-4th March).
The data presented was from Lombard's Retrospective Aorfix™ Data Retrieval ("RADAR") voluntary registry for all Aorfix™ customers. Dr Phillips stated that the Aorfix™ device has been utilized in the largest series of patients with difficult and tortuous anatomy ever studied, yet still had outstanding clinical results, highlighted by a very low incidence of stent migration (0%), wire fracture (<0.25%) and graft limb occlusion (<0.25%) at 12 months in the data set of 461 eligible patients
In the session attended by many of the leading vascular interventionalists in the country, Dr Phillips also gave a brief update on recruitment into Lombard's pivotal FDA study for Aorfix™ in which he stated that, to date, more than 175 patients had been recruited into the trial, and that the Company requires 160 patients with follow-up to 12 months for submission to the FDA (minimum 40 low angle and 120 high angle). The Company has now recruited patients in excess of the minima and is on track to have the required number of patients with appropriate follow-up completed during the first half of 2011.
I will keep topping up with spare funds as I can till next year, I think 2011 will be the year we have all been waiting for..
Regads and GLTA